-Reuters
Truist Securities Maintains Buy on Rapid7, Lowers Price Target to $80
Truist Securities analyst Joel Fishbein maintains Rapid7 (NASDAQ:RPD) with a Buy and lowers the price target from $95 to $80.
Related Posts
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
Needham Maintains Buy on Artivion, Lowers Price Target to $29
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $30 to $29.
RBC Capital Maintains Outperform on Datadog, Lowers Price Target to $105
RBC Capital analyst Matthew Hedberg maintains Datadog (NASDAQ:DDOG) with a Outperform and lowers the price target from $125 to $105.